Dr. Maria Millan, President and CEO of CIRM, attended the meeting to discuss the importance of having systems in place for patient protection. What procedures are in place to ensure the quality and safety of stem cell treatments? How can patients guard against deceptive promotional practices for treatments that have no basis in science? What … Continue reading California Stem Cell and Regenerative Therapy Task Force holds meeting to consider options for patient protection